Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Schizophrenia

Interventions

DRUG

TAK-058

TAK-058 oral solution.

DRUG

Ondansetron

Ondansetron capsule.

DRUG

TAK-058 Placebo

TAK-058 placebo-matching, solution.

DRUG

Ondansetron Placebo

Ondansetron placebo-matching, capsule.

Trial Locations (1)

St Louis